107 related articles for article (PubMed ID: 2961004)
1. Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy.
Bottomley PA; Herfkens RJ; Smith LS; Bashore TM
Radiology; 1987 Dec; 165(3):703-7. PubMed ID: 2961004
[TBL] [Abstract][Full Text] [Related]
2. The fate of inorganic phosphate and pH in regional myocardial ischemia and infarction: a noninvasive 31P NMR study.
Bottomley PA; Smith LS; Brazzamano S; Hedlund LW; Redington RW; Herfkens RJ
Magn Reson Med; 1987 Aug; 5(2):129-42. PubMed ID: 3657502
[TBL] [Abstract][Full Text] [Related]
3. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium.
Bottomley PA; Weiss RG
Radiology; 2001 May; 219(2):411-8. PubMed ID: 11323465
[TBL] [Abstract][Full Text] [Related]
5. [Localized 31 phosphorus NMR spectroscopy of the human heart--development of a measuring method and initial clinical application].
Friedrich M; Weikl A; Sauter R; Reinhardt ER; Bachmann K
Z Kardiol; 1991 Apr; 80(4):266-71. PubMed ID: 1862667
[TBL] [Abstract][Full Text] [Related]
6. Exercise-induced decrease in myocardial high-energy phosphate metabolites in patients with Chagas heart disease.
Betim Paes Leme AM; Salemi VM; Weiss RG; Parga JR; Ianni BM; Mady C; Kalil-Filho R
J Card Fail; 2013 Jul; 19(7):454-60. PubMed ID: 23834921
[TBL] [Abstract][Full Text] [Related]
7. Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T
Valkovič L; Clarke WT; Schmid AI; Raman B; Ellis J; Watkins H; Robson MD; Neubauer S; Rodgers CT
J Cardiovasc Magn Reson; 2019 Mar; 21(1):19. PubMed ID: 30871562
[TBL] [Abstract][Full Text] [Related]
8. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization.
Prabhakar G; Vona-Davis L; Murray D; Lakhani P; Murray G
J Am Coll Surg; 2003 Nov; 197(5):786-91. PubMed ID: 14585415
[TBL] [Abstract][Full Text] [Related]
9. Reperfused-viable and reperfused-infarcted myocardium: differentiation with in vivo P-31 MR spectroscopy.
Rehr RB; Tatum JL; Hirsch JI; Quint R; Clarke G
Radiology; 1989 Jul; 172(1):53-8. PubMed ID: 2740521
[TBL] [Abstract][Full Text] [Related]
10. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
Auffermann W; Chew WM; Wolfe CL; Tavares NJ; Parmley WW; Semelka RC; Donnelly T; Chatterjee K; Higgins CB
Radiology; 1991 Apr; 179(1):253-9. PubMed ID: 2006287
[TBL] [Abstract][Full Text] [Related]
11. Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy.
Levine SR; Helpern JA; Welch KM; Vande Linde AM; Sawaya KL; Brown EE; Ramadan NM; Deveshwar RK; Ordidge RJ
Radiology; 1992 Nov; 185(2):537-44. PubMed ID: 1410369
[TBL] [Abstract][Full Text] [Related]
12. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease.
Weiss RG; Bottomley PA; Hardy CJ; Gerstenblith G
N Engl J Med; 1990 Dec; 323(23):1593-600. PubMed ID: 2233948
[TBL] [Abstract][Full Text] [Related]
13. [The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].
Beer M; Landschütz W; Meininger M; Seyfarth T; Viehrig M; Sandstede J; Pabst T; Kenn W; Horn M; Harre K; von Kienlin M; Neubauer S; Hahn D
Rofo; 1999 Jul; 171(1):65-8. PubMed ID: 10464508
[TBL] [Abstract][Full Text] [Related]
14. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka KV; Ertl G; Gold R; Hahn D
Rofo; 2001 May; 173(5):399-404. PubMed ID: 11414146
[TBL] [Abstract][Full Text] [Related]
15. Clinical cardiac magnetic resonance spectroscopy--present state and future directions.
Neubauer S; Horn M; Hahn D; Kochsiek K
Mol Cell Biochem; 1998 Jul; 184(1-2):439-43. PubMed ID: 9746338
[TBL] [Abstract][Full Text] [Related]
16. [Effect of rehabilitation after myocardial infarction on muscular metabolism. Contribution of phosphorus 31 NMR spectroscopy].
Cottin Y; Marcer I; Walker P; Verges B; Caillaux BX; Louis P; Didier JP; Casillas JM; Brunotte F; Wolf JE
Arch Mal Coeur Vaiss; 1994 Jun; 87(6):759-65. PubMed ID: 7702419
[TBL] [Abstract][Full Text] [Related]
17. [The effect of Belzer and Bretschneider cardioplegia solutions on myocardial energy metabolism. A study with 31phosphorus magnetic resonance spectroscopy in an animal model].
Brinkmann G; Burkhart C; Clausen M; Henze E
Z Kardiol; 1992 Jun; 81(6):339-44. PubMed ID: 1496855
[TBL] [Abstract][Full Text] [Related]
18. Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants.
Bottomley PA; Weiss RG; Hardy CJ; Baumgartner WA
Radiology; 1991 Oct; 181(1):67-75. PubMed ID: 1887057
[TBL] [Abstract][Full Text] [Related]
19. Cine-MRI and (31)P-MRS for evaluation of myocardial energy metabolism and function following coronary artery bypass graft.
Zhang Z; Li J; Wu S; Liu Y; Fan Z; Zhou X; Zhao H; Li D; Huan Y
Magn Reson Imaging; 2010 Sep; 28(7):936-42. PubMed ID: 20444565
[TBL] [Abstract][Full Text] [Related]
20. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
